The role of angiogenin-induced rRNA transcription in lymphangiogenesis
| Project/Area Number |
24792213
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | Okayama University |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
SHIBATA Akane 岡山大学, 大学院, 大学院生
KUWAJIMA Daisuke 岡山大学, 大学院, 大学院生
MORISAWA Ayaka 岡山大学, 大学院, 大学院生
|
|---|
| Project Period (FY) |
2012-04-01 – 2014-03-31
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2012: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Keywords | リンパ管新生 / 血管新生 |
|---|
| Research Abstract |
ANG plays a significant role in angiogenesis. Lymphoedema is a refractory disorder that is difficult to be treated with conventional therapy. We therefore investigated whether ANG promotes lymphangiogenesis and improves lymphoedema. Administration of ANG and VEGF-C to mice with tail lymphoedema resulted in a decrease in lymphoedema thickness. ANG and VEGF-C treatment increased the number of lymphatic vessels in the injury site.The effects of ANG and VEGF-C on lymphatic endothelial cells were investigated. ANG and VEGF-C promoted ANG nuclear translocation and cell proliferation in lymphatic endothelial cells. Angiogenin-induced lymphangiogenesis is a possible new therapeutic strategy for lymphoedema.
|
Report
(3 results)
Research Products
(9 results)
